Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
69
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Nuclear Transcription Factor-kappaB in Hodgkin's Disease

Anas Younes Department of Lymphoma/Myeloma, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429 Houston, TX, USA
,
Amit Garg Cytokine Research Section, Department of Bioimmunotherapy, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 143 Houston, TX, USA
&
Bharat B. Aggarwal Cytokine Research Section, Department of Bioimmunotherapy, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 143 Houston, TX, USA
Pages 929-935 | Published online: 01 Jul 2009

  • Sen, R. and Baltimore, D. (1986) "Multiple nuclear factors interact with the immunoglobulin enhancer sequences", Cell 46, 705-716.
  • Baldwin, A.S. (2001) "Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB", J. Clin. Invsetig. 107, 241-246.
  • Yamamoto, Y. and Gaynor, R.B. (2001) "Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer", J. Clin. Investig. 107, 135-142.
  • Garg, A. and Aggarwal, B.B. (2002) "Nuclear transcription factor-kappaB as a target for cancer drug development", Leukemia 16, 1053-1068.
  • Chen, F.E. and Ghosh, G. (1999) "Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views", Oncogene 18, 6845-6852.
  • Mackay, F. Majeau, G.R., Hochman, P.S. and Browning, J.L. (1996) "Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types", J. Biol. Chem. 271, 24934-24938.
  • Mukhopadhyay, A., Manna, S.K. and Aggarwal, B.B. (2000) "Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha", J. Biol. Chem. 275, 8549-8555.
  • Livolsi, A., Busuttil, V., Imbert, V, Abraham, R.T. and Peyron, J.F. (2001) "Tyrosine phosphorylation-dependent activation of NFkappaB. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases", Eur. J. Biochem., 268, 1508-1515.
  • Bui, N.T., Livolsi, A., Peyron, J.F. and Prehn, J.H. (2001) "Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha", J. Cell. Biol. 152, 753 764.
  • Koong, A.C., Chen, E.Y. and Giaccia, A.J. (1994) "Hypoxia causes, the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues", Cancer Res. 54, 1425-1430.
  • Imbert, V., Rupec, R.A., Livolsi, A., Pahl, H.L., Traenckner, E.B., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P.A. and Peyron, J.F. (1996) 'Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha", Cell 86, 787-798.
  • Digicaylioglu, M. and Lipton, S.A. (2001) "Erythropoietinmediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades", Nature 412, 641-647.
  • Raju, U., Gumin, G.J., Noel, F. and Tofilon, P.J. (1998) "IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumor cells", Int. J. Radiat. Biol. 74, 617-624.
  • Kang, J.L., Pack, I.S., Hong, S.M., Lee, H.S. and Castranova, V. (2000) "Silica induces nuclear factor-kappaB activation through tyrosine phosphorylation of I kappa B-alpha in RAW264.7 macrophages", Toxicol. Appl. Pharmacol. 169, 59-65.
  • Geng, Y., Zhang, B. and Lotz, M. (1993) "Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes", J. Immunol. 151, 6692-6700.
  • Yoza, B.K., Hu, J.Y. and McCall, C.E. (1996) "Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1 beta and NFkappaB activation, but nol NFkappaB nuclear translocation", J. Biol. Chem. 271, 18306-18309.
  • Usami, I., Kubota, M., Bessho, R., Kataoka, A., Koishi, S., Watanabe, K., Sawada, M., Lin, Y.W., Akiyama, Y. and Furusho, K. (1998) "Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-kappa B activation", Biochem. Pharmacol. 55, 185-191.
  • Natarajan, K., Manna, S.K., Chaturvedi, M.M. and Aggarwal, B.B. (1998) "Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappa B. degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression", Arch. Biochem. Biophys. 352, 59-70.
  • Kang, J.L., Lee, H.W., Lee, H.S., Pack, I.S., Chong, Y. Castranova, V. and Koh, Y. (2001) "Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide", Am. J. Respir. Crit. Care Med. 164, 2206-2212.
  • Mahon, T. M. and O'Neill, L.A. (1995) "Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit", J. Biol. Chem. 270, 28557-28564.
  • Abu-Amer, Y., Ross, F.P., McHugh, K.P., Livolsi, A., Peyron, J.F. and Teitelbaum, S.L. (1998) "Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of IkappaBalpha", J. Biol. Chem. 273, 29417-29423.
  • Eicher, D.M., Tan, T.H., Rice, N.R., O'Shea, J.J. and Kennedy, I.C. (1994) "Expression of v-src in T cells correlates with nuclear expression of NT-kappa B", J. Immunol. 152, 2710-2719.
  • Koong, A.C., Chen, E. Y. Mivechi, N.F., Denko, N.C., Stambrook, P. and Giaccia, A.J. (1994) "Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERR1 or ERK2)", Cancer Res. 54, 5273-5279.
  • Manna, S.K. and Aggarwal, B.B. (2000) "Differential requirement for p561ck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa 8. activator protein-1. c-Jun N-terminal kinase. and apoptosis", J. Immunol. 164, 5156-5166.
  • Manna, S.K., Sah, N.K. and Aggarwal, B.B. (2000) "Protein tyrosine kinase p561ck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis', J. Biol. Chem. 275, 13297-13306.
  • Klug, C.A., Gerely, S.J., Shah, P.C., Chen, Y.Y. Rice, N.R., Rosenberg, N. and Singh, H. (1994) "The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes", Genes Dev 8, 678-687.
  • Singh, S. and Aggarwal, B.B. (1995) "Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B", J. Biol. Chem. 270, 10631-10639.
  • Singh, S., Darnay, B.G. and Aggarwal, B.B. (1996) "Site-specific tyrosine phosphorylation of lkappaBalpha negatively regulates its inducible phosphorylation and degradation", J. Biol. Chem. 271, 31049-31054.
  • Menon, S.D., Qin, S., Guy, G.R. and Tan, Y.H. (1993) "Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation", J. Biol. Chem. 268, 26805-26812.
  • Kalesnikoff, J., Baur, N., Leitges, M. Hughes, M.R., Damen, J.E., Huber, M. and Krystal, G. (2002) "SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NFkappa B activity", J. Immunol. 168, 4737-4746.
  • Aghajanian, C., Soignet, S., Dizon, D.S., Pien, C.S., Adams, J., Elliotl, P.J., Sabbatini, P., Miller, V., Hensley, M.L., Pezzulli, S., Canales, C. Daud, A. and Spriggs, D.R. (2002) "A phase I trial of the novel proteasome inhibitor P-S341 in advanced solid tumor malignancies", Clin. Cancer Res. 8, 2505-2511.
  • Staudt, L.M. (2000) "The molecular and cellular origins of Hodgkin's disease", J. Exp. Med. 191, 207-212.
  • Bargou, R.C., Leng, C., Krappmann, D., Emmerich, F., Mapara, M. Y. Bommert, K., Royer, H.D., Scheidercit, C. and Dorken, B. (1996) "High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells", Blood 87, 4340-4347.
  • Bargou, R.C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M.Y., Arnold, W., Royer, H.D., Grinstein, E., Greiner, A., Scheidereit, C. and Dorken, B. (1997) "Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells", J. Clin. Investig., 100, 2961-2969.
  • Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H. and Dorken, B. (1999) "Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells", Blood 94, 3129-3134.
  • Cabannes, E., Khan, G., Aillet, F., Jarrett, R.F. and Hay, R.T. (1999) "Mutations in the IkBa gene in Hodgkin's disease suggest a tumor suppressor role for IcappaBalpha", Oncogene 18, 3063-3070.
  • Jungnickel, B., Staratschek-Jox, A., Brauninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M.L., Rajewsky, K. and Kuppers, R. (2000) "Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma", J. Exp. Med. 191, 395-402
  • Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dorken, B. and Scheidereit, C. (1999) "Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells", Oncogene 18, 943-953.
  • Gruss, H.J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997) "Hodgkins disease-a tumor with disturbed immunological pathways", Immunol. Today 18, 156-163.
  • Fiumara, P., Snell, V. Li, Y. Mukhopadhyay, A., Younes, M., Gillenwater, A.M., Cabanillas, F., Aggarwal, B.B. and Younes, A. (2001) "Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines", Blood 98, 2784-2790.
  • Foss, H.D., Herbst, H., Gottstein, S., Demel, G., Araujo, I. and Stein, H. (1996) "Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density", Am. J. Pathol. 148, 1229-1236.
  • Gruss, H.J., Ulrich, D., Dower, S.K., Herrmann, F. and Brach, M.A. (1996) "Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor", Blood 87, 2443-2449.
  • Horie, R., Aizawa, S., Nagai, M., Ito, K., Higashihara, M., Ishida, T., Inoue, J. and Watanabe, T. (1998) "A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation '. Int. Immunol. 10, 203-210.
  • Lee, S.Y., Kandala, G., Liou, M.L., Liou, H.C. and Choi, Y. (1996) "CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity", Proc. Natl Acad. Sci. USA 93, 9699-9703.
  • Horie, R., Watanabe, T., Morishita, Y. Ito, K., Ishida, T., Kanegae, Y. Saito, I., Higashihara, M., Mori, S. and Kadin, M.E. (2002) "Ligand-independent signaling by overexpressed CD30 drives NFkappaB activation in Hodgkin-Reed Sternberg cells", Oncogene 21, 2493-2503.
  • Ansieau, S., Scheffrahn, I., Mosialos, G., Brand, H., Duyster, J., Kaye, K., Harada, J., Dougall, B., Hubinger, G., Kieff, E., Herrmann, F., Leutz, A. and Gruss, H.J. (1996) "Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2 and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation", Proc. Nat. Acad. Sci. USA 93, 14053-14058.
  • Eliopoulos, A.G., Stack, M., Dawson, C.W., Kaye, K.M., Hodgkin, L., Sihota, S., Rowe, M. and Young, L.S. (1997) "Epstein-Barr virus-encoded LMPI and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors", Oncogene 14, 2899-2916.
  • Lee, H.H., Dempsey, P.W., Parks, T.P., Zhu, X., Baltimore, D. and Cheng, G. (1999) "Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up- regulation", Proc. Natl Acad. Sci USA 96, 1421-1426.
  • Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B. and Scheidereit, C. (2001) "Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86 and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells", Blood 97, 2798-2807.
  • Boucher, L.M., Marengere, L.E., Lu, Y., Thukral, S. and Mak, T.W. (1997) "Binding sites of cytoplasmic effectors TRAF1. 2, and 3 on CD30 and other members of the TNF receptor superfamily", Biochem. Biophys. Res. Commun. 233, 592-600.
  • Duckett, C.S., Gedrich, R.W., Gilfillan, M.C. and Thompson, C.B. (1997) "Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2", Mol. Cell. Biol. 17, 1535-1542.
  • Kieff, E. (1997) "Tumor necrosis factor receptor-associated factor (TRAF)-1. TRAF-2 and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation", Proc. Natl Acad. Sci. USA 94, 12732.
  • Pullen, S.S., Dang, T.T., Crute, J.J. and Kehry, M.R. (1999) "CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs", J. Biol. Chem. 274, 14246-14254.
  • Kosaka, Y., Calderhead, D.M., Manning, E.M., Hambor, J.E., Black, A., Geleziunas, R., Marcu, K.B. and Noelle, R.J. (1999) "Activation and regulation of the IkappaB kinase in human B cells by CD40 signaling", Eur. J. Immunol. 29, 1353-1362.
  • Durkop, H., Foss, H.D., Demel, G., Klotzbach, H., Hahn, C. and Stein, H. (1999) 'Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstei-Barr virus-transformed lymphoid cells", Blood 93, 617-623
  • Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., van der Heiden, A., Itie, A., Wakeham, A., Khoo, W., Sasaki, T., Cao, Z., Penninger, J.M., Paige, C.J., Lacey, D.L., Dunstan, C.R., Boyle, W.J., Goeddel, D.V. and Mak, T.W. (1999) "TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling", Genes Dev. 13, 1015-1024.
  • Darnay, B.G., Ni, J., Moore, P.A. and Aggarwal, B.B. (1999) "Activation of NF-kappaB by RANK requires tumor necrosis factor receptor- associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif, J. Biol. Chem. 274, 7724-7731.
  • Wong, B.R., Josien, R., Lee, S.Y., Vologodskaia, M., Steinman, R.M. and Choi, Y. (1998) "The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor", J. Biol. Chem. 273, 28355-28359.
  • Darnay, B.G., Haridas, V., Ni, J., Moore, P.A. and Aggarwal, B.B. (1998) "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor- associated factors and activation of NF-kappaB and c-Jun N-terminal kinase", J. Biol. Chem. 273, 20551-20555.
  • Eliopoulos, A.G., Dawson, C.W., Mosialos, G., Floettmann, J.E., Rowe, M., Armitage, R.J., Dawson, J., Zapata, J.M., Kerr, D.J., Wakelam, M.J., Reed, J.C., Kieff, K. and Young, L.S. (1996) "CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMPl: involvement of TRAF3 as a common mediator", Oncogene 13, 2243-2254.
  • Ardila-Osorio, H., Clausse, B., Mishal, Z., Wiels, J., Tursz, T. and Busson, P. (1999) "Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells", Int. J. Cancer 81, 645-649.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.